My Cart

ALPP

ALPP Overview

English NameAlkaline phosphatase, placental typeApproved Drugs0
Drugs in Clinical Trials2Target SynonymAlkaline phosphatase Regan isozyme,Placental alkaline phosphatase 1,PLAP-1
Highest Development StagePhase 2 Clinical
English NameAlkaline phosphatase, placental type
Target SynonymAlkaline phosphatase Regan isozyme,Placental alkaline phosphatase 1,PLAP-1
Approved Drugs0
Drugs in Clinical Trials2
Highest Development StagePhase 2 Clinical

ALPP Product List

  • Product Category

    Protein (4)Antibody (1)

  • Product Status

    Launched (5)

  • Species

    Cynomolgus (1)Human (2)Mouse (1)Rat (1)

  • Tag

    His Tag (3)- (1)His Tag & Avi Tag (1)

  • Conjugate

    Unconjugated (4)Biotin-labeled (1)

ALPP Background

Placental alkaline phosphatase (ALPP) is a membrane-bound enzyme normally restricted to placental tissue. However, it is aberrantly overexpressed in various solid tumors, including ovarian, testicular, and cervical cancers, making it a highly specific tumor biomarker. High-affinity anti-ALPP antibodies are essential for early clinical cancer diagnostics (IHC/serum screening) and the development of targeted therapies like antibody-drug conjugates (ADCs) and CAR-T cells.

ALPP Synonyms

PLAP

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
Retroviral vector-transduced autologous T cells to express anti-ALPP CARs (TCRCure Biopharma Corporation)Phase 2 ClinicalXinqiao Hospital, Army Medical UniversityEndometrial Neoplasms; Ovarian Neoplasms; Solid tumours
Details
anti-ALPP CAR T-cell therapy (TCRCure Biopharma)TC-A101Phase 1 ClinicalTcrcure Biopharma LtdSolid tumours
Details
  • Product List
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland